Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
Найдено в других БД
Формат представления найденных документов:
библиографическое описаниекраткийполный
Поисковый запрос: (<.>S=ИНТЕГРИН ТРОМБОЦИТОВ<.>)
Общее количество найденных документов : 1
1.
РЖ ВИНИТИ 34 (BI39) 95.11-04К1.40

    Gao, Jingbo.

    An enzyme-linked immunosorbent assay to identify inhibitors of activation of platelet integrin 'альфа'[IIb]'бета'[3] [Text] / Jingbo Gao, Sanford J. Shattil // J. Immunol. Meth. - 1995. - Vol. 181, N 1. - P55-64 . - ISSN 0022-1759
Перевод заглавия: Твердофазный иммуноферментный метод для выявления ингибиторов активации интегрина 'альфа'[IIb]'бета'[3] тромбоцитов
Аннотация: The affinity of integrin 'альфа'[IIb]'бета'[3] for adhesive ligands is tightly regulated by the platelet such that fibrinogen binding is observed only after platelet activation. Ligand binding is necessary for platelet aggregation, which contributes to vascular occlusion in pathological states. Therefore, we have developed an ELISA assay to screen for compounds that inhibit 'альфа'[IIb]'бета'[3] activation. Washed platelets were incubated in microtitre wells with potential inhibitory compounds and stimulated with an agonist to activate 'альфа'[IIb]'бета'[3]. After the addition of biotin-PAC1, a fibrinogen-mimetic monoclonal antibody, the activation state of 'альфа'[IIb]'бета'[3] was measured by sedimenting the platelets and quantitating the residual biotin-PAC1 in the cell-free supernatant in a streptavidin-based ELISA. This assay detected (1) specific PAC1 binding to activated platelets in response to a variety of agonists, and (2) dose-dependent inhibition of PAC1 binding by function-blocking anti-'альфа'[IIb]'бета'[3] monoclonal antibodies, by the tetrapeptide, RGDS, and by an 'альфа'[IIb]'бета'[3]-selective RGD peptidomimetic. Furthermore, the assay detected inhibition of PAC1 bindung by intracellular inhibitors of platelet activation, including bisindolylmaleimide, a selective protein kinase C antagonist, and wortmannin, an inhibitor of phosphatidylinositol 3-kinase. These studies demonstrate that this integrin activation ELISA can detect pharmacological blockade of platelet 'альфа'[IIb]'бета'[3] by extracellular and intracellular inhibitors. Its use may facilitate the search for clinically useful anti-platelet drugs. США, Div. Hematology-Oncology, Univ. Pennsylvania Med. Ctr., Philadelphia, PA 19104. Библ. 27
ГРНТИ  
ВИНИТИ 341.43.05.07
Рубрики: ИНТЕГРИН ТРОМБОЦИТОВ
ИНГИБИТОР

ВЫЯВЛЕНИЕ

ТВЕРДОФАЗНЫЙ ИММУНОФЕРМЕНТНЫЙ МЕТОД

ЧЕЛОВЕК


Доп.точки доступа:
Shattil, Sanford J.


 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)